In our review, we noticed that IL-15 increased with the administration of the SSRI escitalopram (one study, moderate depression [191]), while it decreased with fluoxetine (one study, depressed patients, week 4) [193] (Table 1 and Figure 2). Here, IL15 is linked to depressive symptom measurement.